[[VIEW_THIS]]

USPTO Alert

USPTO posts recordings of USPTO-FDA joint public listening session

The United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) held a joint public listening session on January 19, 2023, to receive public input on USPTO-FDA collaboration initiatives. The recordings of this listening session are now available on the USPTO-FDA engagements webpage. A transcript of the listening session will be posted soon.  

Read the full text of the notice in the Federal Register. Written comments will be accepted until February 6, 2023. Find more information about the USPTO-FDA collaboration on the USPTO-FDA collaboration initiatives webpage.

​​​

Stay connected with the USPTO by subscribing to regular email updates.

Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.

This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov.